CM
EIGR

Caption Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Caption Management’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,757
Closed -$622K – 1827
2022
Q3 		$622K Buy
+2,757
New +$678K 0.01% 1013

Other funds holding EIGR

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Caption Management's EIGR Position: Q4 2022 in Review

Caption Management sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q4 2022, closing a stake of 325 shares — an estimated $39K sold.

Caption Management first reported a position in EIGR in Q3 2022 and held it in 1 quarter. The position peaked at $74K in Q3 2022. 81 funds tracked by Wall St. Rank hold EIGR as of Q4 2022.

  • Caption Management reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • Caption Management sold 325 Eiger BioPharmaceuticals, Inc. shares in Q4 2022, an estimated $39K.
  • Caption Management first reported a position in Eiger BioPharmaceuticals, Inc. in Q3 2022 and held it in 1 quarter.
  • Caption Management's Eiger BioPharmaceuticals, Inc. position peaked at $74K in Q3 2022.
  • 81 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q4 2022.

Based on Caption Management's 13F filing for Q4 2022, filed 14 Feb 2023.